Bellevue Group AG
- SEC CIK
- 0001674546
- Latest filing
- Aug 14, 2026
Holdings in Q2 2024
Holdings as of Jun 30, 2024, filed Aug 14, 2024. Long positions only; changes compare share counts with Q1 2024.
- Positions
- 166
- −3 vs. Q1 2024
- Portfolio value
- $6.15B
- −$402.5M (−6.1%) vs. Q1 2024
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| SILKSilk Road Medical Inc | COM | 855,293 | $23.1M | 0.4% | −662,937−43.7% | Reduced | History |
| NTRANatera, Inc. | COM | 213,987 | $23.2M | 0.4% | −55,845−20.7% | Reduced | History |
| TMOThermo Fisher Scientific Inc. | Stock | 42,626 | $23.6M | 0.4% | +2,670+6.7% | Added | History |
| ANNXAnnexon, Inc. | COM | 5,157,290 | $25.3M | 0.4% | +2,975,000+136.3% | Added | History |
| EWTXEdgewise Therapeutics, Inc. | COM | 1,428,929 | $25.7M | 0.4% | +1,428,929 | New | History |
| CSTLCastle Biosciences Inc | COM | 1,217,101 | $26.5M | 0.4% | −2,984−0.2% | Reduced | History |
| MCKMcKesson Corp | Stock | 46,142 | $26.9M | 0.4% | +37,145+412.9% | Added | History |
| CNCCentene Corp | Stock | 421,458 | $27.9M | 0.5% | +58,358+16.1% | Added | History |
| RMDResmed Inc | COM | 155,881 | $29.8M | 0.5% | +125,490+412.9% | Added | History |
| TMDXTransMedics Group, Inc. | COM | 201,415 | $30.3M | 0.5% | −162,649−44.7% | Reduced | History |
| VEEVVeeva Systems Inc | Stock | 168,583 | $30.9M | 0.5% | +336+0.2% | Added | History |
| EVHEvolent Health, Inc. | CL A | 1,669,835 | $31.9M | 0.5% | +186,739+12.6% | Added | History |
| BEAMBeam Therapeutics Inc. | COM | 1,418,121 | $33.2M | 0.5% | +225,000+18.9% | Added | History |
| CRSPCRISPR Therapeutics AG | NAMEN AKT | 617,649 | $33.4M | 0.5% | −2,301−0.4% | Reduced | History |
| REGNRegeneron Pharmaceuticals, Inc. | COM | 32,297 | $33.9M | 0.6% | +25,220+356.4% | Added | History |
| GMEDGlobus Medical Inc | Stock | 497,293 | $34.1M | 0.6% | −82,605−14.2% | Reduced | History |
| COOCooper Companies, Inc. | COM | 397,373 | $34.7M | 0.6% | 00.0% | Unchanged | History |
| ALGNAlign Technology Inc | COM | 143,982 | $34.8M | 0.6% | −10,927−7.1% | Reduced | History |
| IMCRImmunocore Holdings plc | ADS | 1,154,654 | $39.1M | 0.6% | +182,400+18.8% | Added | History |
| OPCHOption Care Health, Inc. | COM NEW | 1,416,879 | $39.2M | 0.6% | −450,384−24.1% | Reduced | History |
| HCAHCA Healthcare, Inc. | COM | 122,304 | $39.3M | 0.6% | −37,399−23.4% | Reduced | History |
| BDTXBlack Diamond Therapeutics, Inc. | COM | 8,517,839 | $39.7M | 0.6% | 00.0% | Unchanged | History |
| SRPTSarepta Therapeutics, Inc. | COM | 252,321 | $39.9M | 0.6% | +800+0.3% | Added | History |
| EXELExelixis, Inc. | COM | 1,803,200 | $40.5M | 0.7% | −100,000−5.3% | Reduced | History |
| GEHCGE HealthCare Technologies Inc. | Stock | 521,017 | $40.6M | 0.7% | +8,787+1.7% | Added | History |
| CICigna Group | Stock | 123,090 | $40.7M | 0.7% | +43,445+54.5% | Added | History |
| PRCTPROCEPT BioRobotics Corp | COM | 669,049 | $40.9M | 0.7% | −221,065−24.8% | Reduced | History |
| EPIXESSA Pharma Inc. | COM NEW | 7,889,583 | $41.5M | 0.7% | 00.0% | Unchanged | History |
| RLAYRelay Therapeutics, Inc. | COM | 6,377,115 | $41.6M | 0.7% | +450,497+7.6% | Added | History |
| AXSMAxsome Therapeutics, Inc. | COM | 516,533 | $41.6M | 0.7% | −168,943−24.6% | Reduced | History |
| MGNXMacrogenics Inc | COM | 9,942,313 | $42.3M | 0.7% | −23,549−0.2% | Reduced | History |
| BIOBio-Rad Laboratories, Inc. | CL A | 155,258 | $42.4M | 0.7% | −1,360−0.9% | Reduced | History |
| LLYEli Lilly & Co | Stock | 49,674 | $45.0M | 0.7% | −8,291−14.3% | Reduced | History |
| IDXXIDEXX Laboratories Inc | COM | 93,358 | $45.5M | 0.7% | 00.0% | Unchanged | History |
| CRLCharles River Laboratories International, Inc. | COM | 232,702 | $48.1M | 0.8% | +3,005+1.3% | Added | History |
| SAGESage Therapeutics, Inc. | COM | 4,464,693 | $48.5M | 0.8% | −8510.0% | Reduced | History |
| ZBHZimmer Biomet Holdings, Inc. | Stock | 449,081 | $48.7M | 0.8% | +166,864+59.1% | Added | History |
| EXASExact Sciences Corp | COM | 1,158,880 | $49.0M | 0.8% | +20,354+1.8% | Added | History |
| PENPenumbra Inc | COM | 282,049 | $50.8M | 0.8% | +100,891+55.7% | Added | History |
| ELVElevance Health, Inc. | Stock | 101,549 | $55.0M | 0.9% | +2,937+3.0% | Added | History |
| CDNACareDx, Inc. | COM | 3,912,575 | $60.8M | 1.0% | −21,431−0.5% | Reduced | History |
| TNDMTandem Diabetes Care Inc | COM NEW | 1,543,267 | $62.2M | 1.0% | −488,621−24.0% | Reduced | History |
| ARVNArvinas, Inc. | COM | 2,390,800 | $63.6M | 1.0% | 00.0% | Unchanged | History |
| INSMINSMED Inc | COM PAR $.01 | 1,021,700 | $68.5M | 1.1% | −1,120,143−52.3% | Reduced | History |
| BHVNBiohaven Ltd. | COM | 2,040,853 | $70.8M | 1.2% | +890,853+77.5% | Added | History |
| MDTMedtronic plc | Stock | 1,001,747 | $78.8M | 1.3% | −5,253−0.5% | Reduced | History |
| BDXBecton Dickinson & Co | Stock | 347,333 | $81.2M | 1.3% | −68,367−16.4% | Reduced | History |
| PODDInsulet Corp | Stock | 435,420 | $87.9M | 1.4% | +141,592+48.2% | Added | History |
| UNHUnitedHealth Group Inc | Stock | 205,675 | $104.7M | 1.7% | +56,956+38.3% | Added | History |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 2,971,615 | $110.0M | 1.8% | +175,000+6.3% | Added | History |
| EWEdwards Lifesciences Corp | Stock | 1,260,461 | $116.4M | 1.9% | +157,325+14.3% | Added | History |
| INCYIncyte Corp | COM | 2,153,504 | $130.5M | 2.1% | +1160.0% | Added | History |
| DXCMDexcom Inc | COM | 1,268,687 | $143.8M | 2.3% | +47,490+3.9% | Added | History |
| ABTAbbott Laboratories | Stock | 1,606,153 | $166.9M | 2.7% | +171,970+12.0% | Added | History |
| AGIOAgios Pharmaceuticals, Inc. | COM | 3,879,548 | $167.3M | 2.7% | −126,452−3.2% | Reduced | History |
| ITCIIntra-Cellular Therapies, Inc. | COM | 2,471,285 | $169.3M | 2.8% | −348,197−12.3% | Reduced | History |
| MRNAModerna, Inc. | Stock | 1,563,735 | $185.7M | 3.0% | −147,354−8.6% | Reduced | History |
| SYKStryker Corp | Stock | 545,934 | $185.8M | 3.0% | +96,594+21.5% | Added | History |
| RVMDRevolution Medicines, Inc. | COM | 5,029,100 | $195.2M | 3.2% | −44,500−0.9% | Reduced | History |
| BSXBoston Scientific Corp | Stock | 2,569,588 | $197.9M | 3.2% | −579,088−18.4% | Reduced | History |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 919,834 | $223.5M | 3.6% | +1,550+0.2% | Added | History |
| ISRGIntuitive Surgical Inc | COM NEW | 539,904 | $240.2M | 3.9% | −142,282−20.9% | Reduced | History |
| NBIXNeurocrine Biosciences Inc | Stock | 1,898,640 | $261.4M | 4.2% | −157,234−7.6% | Reduced | History |
| VRTXVertex Pharmaceuticals Inc | Stock | 593,461 | $278.2M | 4.5% | −75,289−11.3% | Reduced | History |
| ARGXArgenx SE | SPONSORED ADR | 691,874 | $297.5M | 4.8% | −119,142−14.7% | Reduced | History |
| IONSIonis Pharmaceuticals Inc | COM | 8,260,434 | $393.7M | 6.4% | −39,080−0.5% | Reduced | History |
Sold out since Q1 2024 (12)
Positions held at the end of Q1 2024 that are gone from this filing.
| Security | Class | Shares in Q1 2024 | Value in Q1 2024 | % of portfolio in Q1 2024 | History |
|---|---|---|---|---|---|
| SWAVShockwave Medical, Inc. | COM | 105,786 | $34.4M | 0.5% | History |
| PACBPacific Biosciences of California, Inc. | COM | 4,592,251 | $17.2M | 0.3% | History |
| SPYSPDR S&P 500 ETF Trust | ETF | 6,660 | $3.48M | 0.1% | History |
| BMYBristol Myers Squibb Co | Stock | 23,436 | $1.27M | <0.1% | History |
| VanEck ETF Trust92189F106 | GOLD MINERS ETF | 33,000 | $1.04M | <0.1% | – |
| VERVVerve Therapeutics, Inc. | COM | 29,200 | $387.8K | <0.1% | History |
| VRDNViridian Therapeutics, Inc. | COM | 19,100 | $334.4K | <0.1% | History |
| SMPLSimply Good Foods Co | COM | 7,900 | $268.8K | <0.1% | History |
| BMEABiomea Fusion, Inc. | COM | 17,800 | $266.1K | <0.1% | History |
| RGNXREGENXBIO Inc. | COM | 12,000 | $252.8K | <0.1% | History |
| BAXBaxter International Inc | Stock | 4,200 | $179.5K | <0.1% | History |
| IONQIonQ, Inc. | COM | 1,107 | $11.1K | <0.1% | History |